These are exposure studies associated with the chemical and all of its children.
|Reference||Associated Study Title||Author's Summary||Study Factors||Stressor||Receptors||Country||Medium||Exposure Marker||Measurements||Outcome|
|1.||Groopman JD, et al. (2014).||In this study we have found that aflatoxin exposure is ubiquitous among at least some of the rural populations of Nepal and Bangladesh, as assessed by a robust mass spectrometry-based albumin adduct biomarker.||Aflatoxin B1||Children | Fetuses | Pregnant females||Bangladesh|Nepal||blood | blood, cord | serum||aflatoxin B1-lysine adduct||Details|
|2.||Yard EE, et al. (2013).||Kenya AIDS Indicator Survey (KAIS)||Our findings suggest that aflatoxin exposure is a public health problem throughout Kenya, and it could be substantially impacting human health.||Aflatoxins||Pregnant females | Study subjects||Kenya||serum||aflatoxin B1-lysine adduct||Details|
|3.||Mitchell NJ, et al. (2017).||Malnutrition and Enteric Disease Study (MAL-ED)||Exposure to aflatoxin (a mycotoxin common in maize and groundnuts) has been associated with childhood stunting in sub-Saharan Africa; in an effort to further our understanding of growth impairment in relation to mycotoxins, biospecimens from a cohort of children in Bhaktapur (Nepal) were assessed for aflatoxin exposure at 15, 24, and 36 months of age.||age||Aflatoxins||Children||Nepal||serum||aflatoxin B1-lysine adduct||Details|